Market Overview

Cabot Wins Royalties from Licensing Deal with Michelin

Related CBT
Top 4 Mid-Cap Stocks In The Specialty Chemicals Industry With The Highest EPS Growth Forecast For Next 5 Years
Cabot Norit Activated Carbon Awarded Two New Contracts for Mercury Removal

Cabot Corporation (NYSE: CBT) announces that it has reached another key milestone in its technology licensing agreement with Manufacture Francaise des Pneumatiques Michelin for use of Cabot's patented elastomer composite technology in tire applications. Regular royalty payments to Cabot have now begun and will extend through fiscal 2022.

Posted-In: News Contracts


Related Articles (CBT)

Around the Web, We're Loving...

Get Benzinga's Newsletters